Home
Regulatory UpdatesSep 15, 2026•1 min read

FDA Approves ANDA 076507 for Fluconazole Tablets

By the PharmaCountry team

FDA has approved ANDA 076507 submitted by TARO for oral Fluconazole tablets in 50‑200 mg strengths; all listed products are marked discontinued.

The U.S. Food and Drug Administration has issued approval for ANDA 076507, submitted by TARO, covering oral Fluconazole tablets. The application lists four tablet products (product numbers 001‑004) with strengths of 50 mg, 100 mg, 150 mg, and 200 mg. All are designated as discontinued marketing status. Submission history includes an original filing on 29 July 2004 and multiple labeling supplements (submission numbers 1‑7) with the most recent on 19 Mar 2015. A manufacturing (CMC) supplement was filed on 9 Jan 2008. No reference drug or reference standard is indicated for these products.

Compiled by the PharmaCountry team · Source: FDA.gov

More articles

View all insights